Newsbot

Antibody Discovery Market to Reach USD 17.68 Billion by 2032, Driven by Rising Demand for Targeted Therapies and Advancements in AI Powered Antibody Engineering – SNS Insider

According to research by SNS Insider, the U.S. Antibody Discovery Market is projected to grow at a CAGR of 8.13%, fueled by expanding biologics pipelines, strategic collaborations, and increased adoption of next generation antibody formats across clinical programs. According to research by SNS Insider, the U.S. Antibody Discovery Market is projected to grow at a CAGR of 8.13%, fueled by expanding biologics pipelines, strategic collaborations, and increased adoption of next generation antibody fo...

99-year-old Lowes and Home Depot rival closing its doors forever

Before Home Depot and Lowes took over the market, local hardware stores used to serve as the center of many communities. Yes, they sold hardware and building supplies, but they also acted as a sort of general store. I remember visiting stores like this as a child, where you buy a shovel, a ...

OpenAI Goes From Stock Market Savior to Anchor as AI Risks Mount

The maker of ChatGPT is no longer seen as being on the cutting edge of AI technology and is facing questions about its lack of profitability and the need to grow rapidly to pay for its massive spending commitments. “OpenAI was the golden child earlier this year, and Alphabet was looked at in a very different light,” said Brett Ewing, chief market strategist at First Franklin Financial Services.

The Cut Countdown

U.S. equity markets near record highs as soft jobs and PCE inflation data boost rate cut hopes.

Autism Spectrum Disorder Market to Reach USD 4.07 Billion by 2033, Driven by Rising Awareness, Early Diagnosis & Advances in Personalized Therapeutics | SNS Insider

According to research by SNS Insider, the U.S. Autism Spectrum Disorder Market is projected to grow at a CAGR of 8.62%, supported by increasing early screening efforts, expanding therapeutic adoption, and momentum in personalized treatment programs. According to research by SNS Insider, the U.S. Autism Spectrum Disorder Market is projected to grow at a CAGR of 8.62%, supported by increasing early screening efforts, expanding therapeutic adoption, and momentum in personalized treatment programs.

Costco makes political move which some members wont like

A number of companies have learned that taking a political stance, or even implying one, can have unintended consequences. President Donald Trump has not hidden the fact that he favors businesses that take actions matching his publicly stated policies. "Trump clearly thinks he can and should bend ...

Prodalim setzt seine beschleunigte strategische Transformation mit der Übernahme von René Laurent, einem führenden Hersteller von Getränkearomen mit Sitz in der Region Grasse, Frankreich, fort

ROTTERDAM, Niederlande--(BUSINESS WIRE)--Prodalim, ein weltweit führender Anbieter von Lösungen für Säfte und Spezialzutaten, gab heute die Übernahme von René Laurent, einem führenden Hersteller von Getränkearomen, von International Flavours & Fragrances Inc. (IFF) bekannt. René Laurent wurde 1885 in der Region Grasse, der Hauptstadt der Aroma- und Duftstoffindustrie in Südfrankreich, gegründet und ist eine traditionsreiche, vertrauenswürdige Marke, die sich auf Aromen für Getränke und einz

What Went Wrong With Capitalism?

Capitalism has reinvented itself many times, from laissez-faire to Keynesianism to the Reagan-Thatcher era. But if the 2008 crisis ended the old model, what replaces it? Bloomberg Opinion’s John Authers and Rockefeller International’s Ruchir Sharma reveal why today’s system feels broken for some: concentrated power, constant bailouts, weak productivity, and shrinking opportunity. They explore whether smarter government, deregulation, and rising global examples like those in Switzerland, Taiwan, ...

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the publication of Phase 1/2 clinical data with PM359, the Company’s investigational autologous hematopoietic stem cell product for p47phox chronic granulomatous disease (CGD) in the New England Journal of Medicine (NEJM). The data will also be presented in a poster session at ...

Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider

SNS Insider Projects U.S. Ophthalmic Drugs Market Growth from USD 14.06 Billion in 2023 to USD 23.11 Billion by 2032, Supported by Strong R&D Investments and Rising Incidence of Eye Disorders. SNS Insider Projects U.S. Ophthalmic Drugs Market Growth from USD 14.06 Billion in 2023 to USD 23.11 Billion by 2032, Supported by Strong R&D Investments and Rising Incidence of Eye Disorders.

What Bubble? Asset Managers in Risk-On Mode Stick With Stocks

For global asset managers who’ve ridden double-digit gains in equities for three straight years, that time is not now. “We are playing the powerful trends in place and are bullish through the end of next year,” said David Bianco, Americas chief investment officer at DWS. “Start the year with sufficient exposure, even over-exposure to equities, predominantly in emerging market equities,” said Nannette Hechler-Fayd’herbe, EMEA chief investment officer at Lombard Odier.

Mutuum Finance (MUTM) Approaches 100% Presale Sellout Amid Ongoing Halborn Security Review

DUBAI, United Arab Emirates, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), an emerging decentralized lending protocol, is approaching a major milestone as its presale moves toward a full Phase 6 sellout. With only a small allocation remaining at the current $0.035 pricing level and the Halborn Security review advancing, the project is drawing increased attention across the DeFi sector as it prepares for its upcoming protocol release.